Product
LY3848575
1 clinical trial
1 indication
Indication
HealthyClinical trial
A Phase 1, Randomized, Double-blind, Placebo-controlled Study to Investigate Safety, Tolerability, and Pharmacokinetics With Single Intravenous Ascending Doses and Single and Multiple Subcutaneous Doses of LY3848575 in Healthy Participants, Including First-generation Japanese ParticipantsStatus: Completed, Estimated PCD: 2024-02-19